How could a patient journey help in building an essential dispatch plan? If a pharma organization comprehends the illness region elements, key bottlenecks and drivers of partner conduct early enough when stage 2 preliminaries are occurring, which means from the beginning dispatch groups are framed at a worldwide level, it can shape the item during improvement to […]
Category Archives: Blogs
Gamification as a tool for enhancing graduate medical education
Gamification is the use of elements of game design to increase user engagement. Gamification has been successfully incorporated into medical and scientific endeavors in recent years, from health/fitness and patient education applications, to genome comparisons (Phylo), protein structure prediction (Foldit) and malaria parasite quantification. Gamification as a tool has proven ability to improve motivation, participation […]
Direct-to-consumer advertising of pharmaceuticals
Direct-to-consumer advertising of pharmaceuticals of prescription drugs is a powerful force in the health care market. Proponents claim that good direct-to-consumer advertising educates and empowers patients in their relationship with their health care providers. Furthermore, they assert that direct-to-consumer advertising provides an opportunity for patients to talk with providers about under-diagnosed and under-treated medical conditions […]
Telemedicine supported by Augmented Reality
In many telemedicine applications, the correct use of medical device at the point of need is essential to provide an appropriate service. Some applications may require untrained people to interact with medical devices and patients: care delivery in transportation, military actions, home care and telemedicine training. Currently, healthcare systems across the world are experiencing perfect […]
Why virtual engagement will be key to pharma strategy in 2021 and beyond
In the immediate aftermath of lockdown measures and travel restrictions, pharma teams initially relied on video calls to meet and collaborate. But this quickly became unwieldy due to the ongoing, multi-stakeholder nature of work across medical affairs, clinical, and commercial divisions. And the pharma strategy in 2021, one-off meetings via video platforms quickly dropped off […]
Why Pharma Needs To Evolve Sales Strategies?
Prescribing decisions in the institutional setting differ and Evolve Sales Strategies, considerably from the retail setting. As noted in the figure below, HCPs are influenced by several parties, both internal and external. While the health of the patient and safety of medications continue to be of paramount importance, over the past several years, financial considerations […]
The True Power of Data-Driven Brand Promotional Planning
Data-driven marketing is the approach of optimizing Brand Promotional Planning based on customer information. Data-driven marketers use customer data to predict their needs, desires and future behaviors. Such insight helps develop personalized marketing strategies for the highest possible return on investment (ROI). But how is data driven marketing different from the traditional marketing? To understand […]
Pharma brand Launch Planning: Build your brand cohort for HCP and patient journey
They say one thing is certain in Pharma brand Launch; understanding patient and HCP journeys is never easy. First you will be faced by a wall of real-word data, each brick different in material, size and shape, formed by diverging internal and external vendor data sources. You must rebuild it brick-by-brick until standardized and linked. […]
Drug launch readiness in 2021 for pharma industry in the Shadow of COVID
It is probably reasonable enough by now to talk about the Drug launch readiness landscape for medicines and vaccines as pre- and post-COVID. We can also say with some certainty that nothing will ever be the same again. The marketing landscape is dynamic as ever, more so with communication routes evolving at lightning speed and […]
Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the available mechanisms for funding research, development, manufacturing, and distribution in the life sciences. The traditional innovation strategy started with scientific discovery supported by grants from governmental and philanthropic sources, followed by product commercialization supported by pharmaceutical industry revenues and capital investments. According to one estimate, governmental […]